Navigation Links
Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
Date:9/1/2013

AMSTERDAM, The Netherlands and OSAKA, Japan, Sept. 2, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) today announced results of the EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) cardiovascular (CV) safety outcomes trial, showing the primary endpoint of non-inferiority compared to placebo in addition to standard of care was met with no increase in CV risk in a Type 2 diabetes patient population at high-risk for CV events. These data, published in the New England Journal of Medicine (NEJM) and also presented at the ESC Congress 2013, demonstrate that alogliptin does not increase CV risk in Type 2 diabetes patients at high-risk for major adverse cardiac events (MACE) due to a recent acute coronary syndrome (ACS). The trial's primary objective was to evaluate non-inferiority of CV risk based on a primary composite endpoint of CV death, nonfatal myocardial infarction and nonfatal stroke. The primary endpoint occurred at similar rates in the alogliptin and placebo groups (in 11.3% of patients vs. 11.8% of patients during a median follow-up period of 18 months; hazard ratio, 0.96; one-sided repeated confidence interval [CI] bound, 1.16). Alogliptin is a dipeptidyl peptidase-4 inhibitor (DPP-4i) for the treatment of Type 2 diabetes in adults to improve glycemic control as an adjunct to diet and exercise.

"There is a need for safer glucose lowering therapies in patients with diabetes who are at an elevated risk for cardiovascular disease," stated William B. White, MD, FASH, FAHA, FACP, principal investigator of the EXAMINE trial. "Given the EXAMINE study design and high-risk patient population evaluated, these results provide key insights to clinicians treating diabetes patients with coronary disease."

The global EXAMINE trial is an im
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimers Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
2. Takeda Launches New Subsidiary in Peru
3. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
4. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
5. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
6. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
7. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
8. Takeda to Acquire Inviragen, Inc.
9. Takeda Responds to Verdict in Diabetes Drug Case
10. Takeda Launches New Subsidiary in Ecuador
11. Takeda lanza nueva subsidiaria en Ecuador
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... , Oct. 2, 2014 Research ... "Global Home Healthcare Market - Industry Analysis, Size, Share, ... to their offering. The home healthcare ... that help patients to treat or diagnose a variety ... important role in providing cost-effective health care to the ...
(Date:10/2/2014)... Oct. 2, 2014  InfinityQS International, Inc., the ... today announces key client speakers for Infusion Chicago, ... . The event will be held Oct. 9-10, ... Presentations include projects from Coloplast, The Kellogg Company, ... Snak King. The two-day event will also include ...
(Date:10/2/2014)... R.I. , Oct. 2, 2014  MinuteClinic, the largest and ... United States , has opened its first walk-in clinics in ... CVS/pharmacy stores in Corpus Christi and ... Corpus Christi in December. The clinics ... clinics nationwide in 2014. With the Corpus Christi ...
Breaking Medicine Technology:Global Home Healthcare (Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies) Market - Trends and Forecast, 2014 - 2020 2Global Home Healthcare (Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies) Market - Trends and Forecast, 2014 - 2020 3InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 2InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 3First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3
... Nov. 6 In,recognition of her research and ... among African-American, South-African and,Latino youth and adults, the ... the selection of Loretta Sweet Jemmott, PhD, RN,FAAN, ... Award. Jemmott was presented with the $15,000 ...
... majority of people,with diabetes and/or high blood pressure ... (CKD) -- are not receiving recommended tests to,identify ... or halt,disease progression, according to the latest Quest ... suggest that patients,with early-stage CKD are not being ...
Cached Medicine Technology:Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 2Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved 3Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 2Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 3Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 4Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 5Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease 6
(Date:10/2/2014)... (PRWEB) October 02, 2014 When a child, ... can be hard to keep them from wandering off. "In ... design," said one of three inventors from Yulee, Fla. , ... person or elderly person and deters them from wandering off. ... of mind. Easy to use and compact, the device can ...
(Date:10/2/2014)... 02, 2014 Social-Engineer, Inc. the leader ... today it will host a complimentary webinar on Friday, ... reveal the final outcome of the annual Social-Engineer Capture ... in Las Vegas and explore how to maximize security ... To register for the webinar go to: ...
(Date:10/2/2014)... Melbourne, Australia (PRWEB) October 02, 2014 ... local markets, organic food is becoming increasingly popular ... Organic Livestock and Poultry Farming industry ... Tonkin, “the popularity of organic meat has surged ... growth and expansion at the farming level.” Over ...
(Date:10/2/2014)... Maureen Salamon ... News) -- Middle-aged women with a neurotic personality style ... developing Alzheimer,s disease, new research suggests. Tracking 800 ... those who were most anxious, jealous and moody -- ... stress had double the risk of developing Alzheimer,s compared ...
(Date:10/2/2014)... News) -- Children with autism are more sedentary than ... being more active, a small study suggests. Researchers ... some with autism and some without. Children with autism ... activity and 70 more minutes each day sitting than ... scored lower on strength, but had similar body-mass index ...
Breaking Medicine News(10 mins):Health News:Social-Engineer, Inc. Announces DEF CON 22 Capture the Flag Results in a Complimentary Webinar 2Health News:Social-Engineer, Inc. Announces DEF CON 22 Capture the Flag Results in a Complimentary Webinar 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Kids With Autism Tend to Be Less Active, Study Says 2
... Pa,s recognized children,s health-care leader, may be faced with harsh ... Edward G. Rendell said today that Pennsylvania families should not ... -- especially during hard economic times -- and urged the ... in the upcoming state budget. , , "The nation ...
... Add to the Growing Body of Research Linking Berry ... and CORVALLIS, Ore., June 24 More than twenty ... on the positive effects of berries on human health ... to mount on the link between consumption of colorful ...
... DENVER, June 24 The National Sports Center for the Disabled and American ... Classic from Friday, July 17th to Sunday, July 19th at the Winter Park ... with a wide variety of well-marked trails for all levels of riders and ... , World Class Mountain Biking! , ...
... chemotherapy regimen often is enough, study finds , WEDNESDAY, ... isn,t necessary for most children with newly diagnosed acute ... doctors from St. Jude Children,s Research Hospital found that ... period and experienced fewer adverse events than those who, ...
... for patients with the Anakam Identity Suite(R) , ... that Sharp HealthCare, San Diego County,s largest healthcare system, ... access for patients accessing Sharp,s new patient portal. ... meet the needs of its patient community by providing ...
... FORT LAUDERDALE, Fla., June 24 Argentech, Inc. ( ... agreement with Invision International Health Solutions, Inc., to purchase ... technology that utilizes ionic silver in a unique complex ... was granted broad patent protection in the U.S. and, ...
Cached Medicine News:Health News:Pennsylvania Governor Rendell Urges General Assembly to Support Children's Health Insurance Program 2Health News:Latest Berry Health Benefits Revealed 2Health News:Latest Berry Health Benefits Revealed 3Health News:Latest Berry Health Benefits Revealed 4Health News:18th Annual Fat Tire Classic Benefiting the National Sports Center for the Disabled & the American Red Cross Mile High July 17th - 19th, 2009 2Health News:For Kids With Leukemia, Radiation May Be Safe to Skip 2Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 2Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 3Health News:Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico 2Health News:Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico 3
... a broad selection of tip ... wide variety of ophthalmic procedures. ... packaged sterile, complete with a ... in the "off " position ...
... Accu-Temp Cauteries provide a broad ... cauterization in a wide variety ... use cautery is packaged sterile, ... to lock switch in the ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
Medicine Products: